HL Financial Services LLC increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 1.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,957 shares of the medical research company’s stock after buying an additional 94 shares during the period. HL Financial Services LLC’s holdings in Agilent Technologies were worth $531,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Cribstone Capital Management LLC raised its position in Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock valued at $125,000 after buying an additional 54 shares during the period. Trust Co. of Vermont raised its position in Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares during the period. CENTRAL TRUST Co raised its position in Agilent Technologies by 15.3% in the first quarter. CENTRAL TRUST Co now owns 2,994 shares of the medical research company’s stock valued at $158,000 after buying an additional 398 shares during the period. Penserra Capital Management LLC raised its position in Agilent Technologies by 9.5% in the first quarter. Penserra Capital Management LLC now owns 3,496 shares of the medical research company’s stock valued at $184,000 after buying an additional 304 shares during the period. Finally, Genovese Burford & Brothers Wealth & Retirement Plan Management LLC raised its position in Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after buying an additional 486 shares during the period.

Shares of Agilent Technologies, Inc. (NYSE:A) opened at 59.33 on Friday. The company’s 50-day moving average price is $60.10 and its 200-day moving average price is $55.69. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $61.84. The firm has a market capitalization of $19.06 billion, a P/E ratio of 33.35 and a beta of 1.30.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.48 by $0.10. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The business’s revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.44 EPS. On average, equities research analysts expect that Agilent Technologies, Inc. will post $2.23 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd were issued a $0.132 dividend. The ex-dividend date was Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.89%. Agilent Technologies’s dividend payout ratio is currently 29.78%.

TRADEMARK VIOLATION NOTICE: “HL Financial Services LLC Buys 94 Shares of Agilent Technologies, Inc. (A)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.watchlistnews.com/hl-financial-services-llc-buys-94-shares-of-agilent-technologies-inc-a/1481118.html.

A has been the topic of several recent research reports. Barclays PLC restated a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a report on Wednesday, July 19th. Deutsche Bank AG reiterated a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Thursday, June 22nd. BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. BTIG Research lifted their price objective on Agilent Technologies from $57.00 to $65.00 and gave the stock a “buy” rating in a research note on Wednesday, May 24th. Finally, Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a research note on Tuesday, May 16th. Two investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $60.12.

In other news, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The shares were sold at an average price of $61.26, for a total transaction of $306,300.00. Following the transaction, the insider now directly owns 45,138 shares of the company’s stock, valued at $2,765,153.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 50,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $59.86, for a total transaction of $2,993,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 112,608 shares of company stock worth $6,737,509.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.